Convertible Debenture round currently open for Early Investors


Raising $2M Pre-Series A Round for Customer Development & Pilot Launch

8 million Stroke Survivors in US

...
Problem

70% have some hand paralysis.

No effective Intervention for Hand = Life Long disability.

Costs ~$46 billion/Year from USA

...
Solution

The MyHandTM System

Digital Neuro Rehab Platform for Home-use

Effective
Portable
Accessible
Neuroplastic
Tele-Rehab
Gamified
IoMT System
...
Opportunity

70% have some hand paralysis.

Razor-RazorBlade Business Model
$5B Market Opportunity

TAKE YOUR REHABILITATION TO NEW HEIGHTS

IRegained: Fast Facts

IRegained is a medical device company developing novel solutions for the physical rehabilitation needs of people with disability.

With a mission to help 100 million stroke survivors with hand function disability from brain injury, IRegained has developed the MyHand™ System – a neuroplasticity research-driven, telemedicine-powered, clinically effective and affordable hand function rehabilitation system.

Key Highlights

Uniquely positioned to provide most of the benefits offered by the currently available robotic solutions -- all at a fraction of the cost
Our unique selling proposition (USP) is that we do not compete directly against any of these solutions; rather, we complement their products by filling a large unmet need.

KEY INDUSTRY

Healthcare, science and engineering, technology, platforms, therapy, telehealth, software, medical devices, rehabilitation, stroke/neuroplasticity, telemedicine

MARKET SIZE

  • TAM: $45B
  • SAM: $5B
  • SOM: $800M

TARGET CUSTOMER

Healthcare, science and engineering, technology, platforms, therapy, telehealth, software, medical devices, rehabilitation, stroke/neuroplasticity, telemedicine

TAKE YOUR REHABILITATION TO NEW HEIGHTS

Enormous Problem

Stroke is a life-changing event.

In most cases (70%), the brain damage from stroke results in impaired hand function. This makes mundane tasks, such as holding a cup, combing hair or toileting -- which able-bodied people take for granted -- almost impossible to do.

Stroke survivors unfortunately have to live with this disability for rest of their lives, depending on personal support workers and caregivers.

Not only does this lead to a very poor overall quality of life for the patient, but also costs the US healthcare system $34 billion annually, not to mention, the lost workdays and negative impact on economic output.

TAKE YOUR REHABILITATION TO NEW HEIGHTS

Disappointing Paradigm

Recovering hand function requires targeted neuro-rehabilitation therapy with intensity and repetition for months and potentially years (10-20 sessions per week).

Furthermore, there are very few clinically validated hand-function rehabilitation devices in the market.

Those that exist are either ineffective (ex: squeeze balls, rubber bands, etc.) because they do not leverage neuroplasticity to recover the brain’s ability to control the hand, or cost prohibitive (e.g. robotic devices >$150,000) and therefore unaffordable.

At a current cost of ~$120-$260 per session for hand function rehabilitation, the total incurred cost adds up to $1,200 – $5,200 per week, which is absolutely unaffordable.

TAKE YOUR REHABILITATION TO NEW HEIGHTS

One Outstanding Solution

IRegained has developed the MyHand™ System, a proprietary hand function rehabilitation system that aims to restore lost hand function in stroke or brain trauma survivors.

The system leverages neuroplasticity, the human brain’s ability to ‘reprogram’ its neural pathways. Backed by 40 years of clinical and scientific research-based evidence and with guidance from accomplished rehab professionals, this system can help people with hand-function disability regain their independence.

TAKE YOUR REHABILITATION TO NEW HEIGHTS

Key Features

The MyHand System is:

Intelligent

Smart device built on proven clinical protocols for targeted hand therapy.

Connected

IoMT-based internet-connected device with built-in IRegained app store to access engaging hand-rehab games.

Neuroplastic

Intelligent algorithms developed through deep scientific research on leveraging neuroplasticity and applying it for motor control recovery.

Built for Tele-Rehab

Integral telemedicine platform for remote rehabilitation in the comfort of patient’s home – particularly critical in COVID-19 Pandemic.

Effective

Proven clinical efficacy in recovery of hand function.

Affordable

Affordable system with attractive financing and leasing options.

Ready for home use

One of the very few rehabilitation systems than can be effectively used in the comfort of home.

TAKE YOUR REHABILITATION TO NEW HEIGHTS

Why We’ll Lead

IRegained is serving a large, poorly met market that has yet to find the solution they need to live a healthier, more functional life.

We offer a compelling value proposition for customers across both B2B and B2C. There is 4-5 month pay back period and strong ROI for clinics and long term-care institutions.

Further, COVID-19 has ignited the telemedicine market, and IRegained's MyHand™ System was designed with telemedicine in mind.

Our offering has a low risk regulatory classification (class 1 classification = faster time to market) with pending patents in US, EU, Canada, China and India (Strong IP = higher competitive barrier).

TAKE YOUR REHABILITATION TO NEW HEIGHTS

Traction & Accomplishments

IRegained MyHand™ System has secured significant interest of purchase from leading clinics and rehabilitation centers with just the MVP version of the system. All the participants of the MyHand System study and customer validation trials are interested to purchase the system, and to-date additional over 12 clinics and 10 hospitals are interested to purchase.
Clinical studies initiated at Baycrest, McMaster University and Sunnybrook Hospital are now about to resume. Awaiting final details.

TAKE YOUR REHABILITATION TO NEW HEIGHTS

Raised over $1.5 M

CAD $ 800 K in Dilutive funding and more in process

ACHIEVED SIGNIFICANT MILESTONES DESPITE COVID 19 CHALLENGES

Commercialization Progress to Date

TAKE YOUR REHABILITATION TO NEW HEIGHTS

Partnerships

IRegained has established a number of key partnerships and is in the process of building a global network of strategic alliances in a number of areas including: Scientific & Clinical Collaboration, R&D, and Commercialization.
Card image cap

Octane Launchpad Alumni, Irvine, CA, USA -- Accelerator

Card image cap

SoCal Bio, CA, USA – Incubator

Card image cap

Canadian Technology Accelerator (CTA Graduate) – Accelerator Program

Card image cap

University City Science Center & Launch Lane Accelerator, Philadelphia, PA, USA – Accelerator

Card image cap

Ionic Mechatronics, Sudbury, ON, Canada – Hardware Development Partner

Card image cap

Synaptic Technologies, Sudbury, ON, Canada – Software Development Partner

Card image cap

NORCAT, Sudbury, ON, Canada -- Incubator

Card image cap

Foundry, Innovation Centre at Laurentian University, Sudbury, ON, Canada - Incubator

Card image cap

Laurentian University, Sudbury, ON, Canada – Academic Research Partner

Card image cap

Cambrian College, Sudbury, ON, Canada -– Academic Research Partner

Card image cap

Health Sciences North and HSNRI, Sudbury, ON, Canada – Clinical Research Partner

Card image cap

Baycrest Hospital, Toronto, ON, Canada

Card image cap

McMaster University, Sudbury, ON, Canada - – Clinical Research Partner

Card image cap

Sunnybrook Hospital, Toronto, ON, Canada -- – Clinical Research Partner

Card image cap

Sheba Medical Center, Tel Aviv, Israel - – Clinical Research Partner

Card image cap

University of Texas, San Antonio, Texas, USA - – Clinical Research Partner

Card image cap

Christian Medical College & Hospital (CMC&H), Vellore, TN, India - Academic & Clinical Research Partner

Card image cap

Cerner India Pvt. Ltd., Bangalore, India – Advanced Technology Development + R&D Partner

OUR ADVISOR

Clinical & Business Advisory Expertise

Clinical and Scientific Advisors
Card image cap

Dr. Jocelyn Harris (Chair, CAB)

Associate Professor, McMaster University

Card image cap

Dr. Julie Vaughan Graham

Physical Therapist, Adjunct Lecturer, University of Toronto.

Card image cap

Dr. Yafi Levanon

Occupational Therapist, Tel Aviv University, Sheba Medical Centre, Israel

Card image cap

Dr. Jed Meltzer

Neuroscientist, Baycrest Hospital, University of Toronto

Card image cap

Dr. Shoba Moses

Clinical Occupational Therapist, Dallas, USA

Card image cap

Dr. Michael Franklyn

Prof. Northern Ontario School of Medicine

Strategic Business Advisors
Card image cap

Peter Dal Bianco

Sudbury, ON Canada

Card image cap

Neelima Firth

Thousand Oaks, CA, USA

Card image cap

David Hood

Long Beach, CA, USA

Card image cap

Rav Sheth

Boston, MA USA

Card image cap

Chad Pallopson

Toronto, ON Canada

Card image cap

Dr. Dennis Reich

Sudbury, ON Canada

BE A PART OF THIS AMAZING JOURNEY

Investment Opportunity

We have a convertible debenture round open till August 31st with additional incentives to early investors . Learn more

Card image cap

For this round, IRegained is seeking a total raise of $2,000,000 USD with ~$1,00,000 USD in soft-circled commitments secured to-date.

The funds will allow us to reach the following milestones:

  • Complete product development and launch our pre-commercial (alpha) prototypes in key clinical test sites (~20 across US and Canada)

  • Gather additional independent clinical data to support payor reimbursement & customer adoption

  • Gather additional independent clinical data to support payor reimbursement & customer adoption

Our anticipated use of funds includes:

TAKE YOUR REHABILITATION TO NEW HEIGHTS

Why Invest?

IRegained is on a mission to help 100 million stroke survivors regain their hand function.

We are strategically poised to serve a large, poorly met market that has yet to find the solution they needed by stroke patients to live a healthier, more functional life.

We have achieved significant milestones, despite odds and challenges from COVID-19.

And with your financial support, we can do so much more.

For more information on this investment opportunity, please contact:

Vineet Johnson, CEO

  • vineet@iregained.ca
  • +1.807.355.6979
  • iregained.ca


Standing united in our dreams to help stroke patients reclaim their lives.


IRegained is a MedTech company developing novel solutions for the physical rehabilitation needs of people with disability. With a mission to help 100 million stroke survivors with hand function disability from brain injury, IRegained has developed the MyHandTM System.

Offices

Head Office

NORCAT, 1545 Maley Drive, Sudbury, ON, P3A 4R7


R&D Office

Unit #1, 764 Notre Dame Avenue, Sudbury, ON P3A 2T4